| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |